TickerFacts.

Compare

Castle Biosciences Inc vs Labcorp Holdings Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearCastle Biosciences Inc
CSTL		Labcorp Holdings Inc.
LH
Year ended2025-12-312025-12-31
Revenue$344.23M$13.95B
Revenue growth (YoY)+3.7%+7.2%
Gross margin79.4% (computed)28.8%
Operating margin-12.4%9.9%
Net margin-7.0%6.3%
Net income-$24.16M$876.50M
EPS (Diluted)-$0.83$10.46
Operating cash flow$64.35M$1.64B
Free cash flow$28.33M$1.21B
Cash & equivalents$116.73M$532.30M
Total assets$578.56M$18.39B
Total liabilities$107.68M$9.76B
Shareholders' equity$470.87M$8.62B
Return on year-end equity-5.1%10.2%
Shares outstanding29.69M82.20M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearCastle Biosciences IncLabcorp Holdings Inc.
Latest$344.23M
Ended 2025-12-31		$13.95B
Ended 2025-12-31
1 year earlier$332.07M
Ended 2024-12-31		$13.01B
Ended 2024-12-31
2 years earlier$219.79M
Ended 2023-12-31		$12.16B
Ended 2023-12-31
3 years earlier$137.04M
Ended 2022-12-31		$11.86B
Ended 2022-12-31
4 years earlier$94.08M
Ended 2021-12-31		$13.14B
Ended 2021-12-31